ArticleAsian Pacific journal of cancer prevention : APJCP2025
Prevalence of Human Papillomavirus Infection in Nakhon Ratchasima, Northeastern Thailand.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the prevalence of high-risk human papillomavirus (hrHPV) in Nakhon Ratchasima province, Thailand, which might lead to the formulation of effective HPV vaccination strategies in the region.
methodsThis study analyzed hrHPV DNA test results, liquid-based cytology findings, and available histological data. The data came from women aged 18 to 62 years who underwent cervical cancer screening in six Nakhon Ratchasima districts: Khon Buri, Soeng Sang, Pak Thong Chai, Nong Bun Mak, Wang Nam Khiao, and Mueang Nakhon Ratchasima. The screening occurred between March 2021 and August 2023. We determined the prevalence of hrHPV infection and performed statistical analysis using chi-square tests and multiple logistic regression.
resultA total of 16,209 hrHPV DNA test results were included in the analysis, revealing an overall hrHPV prevalence of 8.03% (1,301/16,209). The most frequently detected category was other hrHPV types (5.62%), followed by HPV type 16 (1.78%) and type 18 (0.62%). A single case of co-infection involving HPV type 16 and another hrHPV type was identified. A significant association between age and hrHPV infection was found (p<0.001), with the highest prevalence occurring in women aged 30-39 years. Additionally, increasing age was significantly linked to a decline in hrHPV infection rates.
conclusionThis study identifies age as a significant risk factor for hrHPV infection. To enhance hrHPV surveillance, we recommend using tests that detect specific HPV types, which will enable a more detailed assessment of prevalence. Furthermore, conducting similar prevalence studies across different regions in Thailand will provide essential data to guide future HPV vaccination policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.